Edgewise Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
June 01 2021 - 09:00AM
Business Wire
Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage
biopharmaceutical company focused on developing orally
bioavailable, small molecule therapies for rare muscle disorders,
today announced that members of its management team will
participate in a fireside chat and one-on-one investor meetings at
the virtual Goldman Sachs 42nd Annual Global Healthcare Conference
on Wednesday, June 9, 2021 at 5:30 p.m. ET.
The fireside chat will be webcast live on the Events and
Presentations page under the investor relations section of Edgewise
Therapeutic’s website at
https://investors.edgewisetx.com/events-and-presentations and
accessible for 90 days following the presentation. It is
recommended that users connect to the webcast several minutes prior
to the start to ensure a timely connection.
About Edgewise Therapeutics Edgewise Therapeutics is a
clinical-stage biopharmaceutical company focused on the discovery,
development and commercialization of innovative treatments for
severe, rare muscle disorders for which there is significant unmet
medical need. Guided by its holistic drug discovery approach to
targeting the muscle as an organ, Edgewise has combined its
foundational expertise in muscle biology and small molecule
engineering to build its proprietary, muscle focused drug discovery
platform. Edgewise’s platform utilizes custom-built high throughput
and translatable systems that measure integrated muscle function in
whole organ extracts to identify small molecule precision medicines
regulating key proteins in muscle tissue, initially focused on
addressing rare neuromuscular and cardiac diseases. To learn more,
go to: www.edgewisetx.com or follow us on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210601005248/en/
Investors & Media Michael Carruthers Chief Financial
Officer ir@edgewisetx.com
Edgewise Therapeutics (NASDAQ:EWTX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Edgewise Therapeutics (NASDAQ:EWTX)
Historical Stock Chart
From Mar 2023 to Mar 2024